[Clinical trials for bladder cancer in Germany].

Area of Science:

• Uro-oncology
• Clinical trial research
• Neoplasia treatment

Context:

• The Association of Urogenital Oncology (AUO) has a decade-long track record of clinical trial execution.
• Approximately 770 patients have been enrolled in Phase I, II, and III trials.
• Trials focused on advanced, inoperable urothelial cancer and adjuvant chemotherapy post-cystectomy for locally advanced bladder cancer.

Purpose:

• To summarize the clinical trial activities and achievements of the AUO's urothelial cancer section.
• To highlight successful patient recruitment for various trial phases.
• To outline future strategic directions for expanding research scope and collaboration.

Summary:

• Over the past decade, the AUO has successfully recruited ~770 patients for urothelial neoplasia clinical trials.
• Significant success was achieved in recruiting patients for advanced-stage disease and adjuvant chemotherapy trials.
• The AUO has published clinical trial results on urothelial neoplasia treatments.

Impact:

• Demonstrates the AUO's significant contribution to advancing urothelial cancer treatment through clinical research.
• Establishes a foundation for future research by identifying needs for expanded centers and international partnerships.
• Facilitates the development of more effective urothelial cancer therapies through collaborative, large-scale studies.